Paragon Biosciences Skyline Capital, LLC — Form D
Paragon Biosciences Skyline Capital, LLC of NORTHBROOK, IL, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-29. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-08-29
- Form: D
- Accession: 0001751269-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Minimum investment: $10K
- Investors: 15
- Date of first sale: 2018-08-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-320343
Issuer
- Name: Paragon Biosciences Skyline Capital, LLC
- CIK: 0001751269
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1033 SKOKIE BOULEVARD, NORTHBROOK, IL, 60062
- Phone: 8477150606
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Jeffrey Aronin | Director | Exton, PA |
| Timothy Cunniff | Director | Chicago, IL |
| Patrick Morris | Director | Chicago, IL |
| Patrick Morris | Executive Officer | Chicago, IL |
More